StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2025Score 0/30
$0.38−0.00 (-0.13%)

Close on Nov 13, 2026Market cap $4.07MP/E –Yield –

Gelteq operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -3317.7%, against -3885.3% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Jun 30, 2025-3317.7%+567.7
FY2023Jun 30, 2023-3885.3%–

More Gelteq figures

See a number that looks wrong?